Results from a clinical trial for a new treatment for alopecia areata were published in the medical journal The Lancet…
As we come to the close of 2022, we look upon these past 12 months as among the most pivotal…
When you participate in a survey that comes to you in a NAAF email, what happens to your responses? For…
Today we received the welcome news that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug…
Today, history was made as the U.S. Food and Drug Administration (FDA) approved Olumiant™ for alopecia areata, marking the first…
